Item 16. Form 10-K Summary

None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


	EDWARDS LIFESCIENCES CORPORATION
February 25, 2026	By:	/s/ BERNARD J. ZOVIGHIAN
		Bernard J. Zovighian Director and Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.


Signature	Title	Date

/s/ BERNARD J. ZOVIGHIAN	Director and Chief Executive Officer	February 25, 2026
Bernard J. Zovighian	(Principal Executive Officer)

/s/ SCOTT B. ULLEM	Corporate Vice President, Chief Financial Officer	February 25, 2026
Scott B. Ullem	(Principal Financial Officer)

/s/ ANDREW M. DAHL	Senior Vice President, Corporate Controller	February 25, 2026
Andrew M. Dahl	(Principal Accounting Officer)

/s/ LESLIE C. DAVIS	Director	February 25, 2026
Leslie C. Davis

/s/ DAVID T. FEINBERG	Director	February 25, 2026
David T. Feinberg

/s/ KIERAN T. GALLAHUE	Director	February 25, 2026
Kieran T. Gallahue

/s/ LESLIE S. HEISZ	Director	February 25, 2026
Leslie S. Heisz

/s/ PAUL A. LAVIOLETTE	Director	February 25, 2026
Paul A. LaViolette

/s/ STEVEN R. LORANGER	Director	February 25, 2026
Steven R. Loranger

/s/ RAMONA SEQUEIRA	Director	February 25, 2026
Ramona Sequeira

/s/ NICHOLAS J. VALERIANI	Chairman of the Board	February 25, 2026
Nicholas J. Valeriani

Previous: Item 15. Exhibits and Financial Statement Schedules